154 related articles for article (PubMed ID: 34610043)
21. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
23. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
[TBL] [Abstract][Full Text] [Related]
24. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
25. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
27. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
Olynyk JK; Platell CF; Collett JA
J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
[TBL] [Abstract][Full Text] [Related]
28. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial.
Griffith JM; Lewis CL; Brenner AR; Pignone MP
BMC Med Inform Decis Mak; 2008 Jan; 8():4. PubMed ID: 18218084
[TBL] [Abstract][Full Text] [Related]
29. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
30. Colorectal carcinoma screening procedure use among primary care patients.
Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
[TBL] [Abstract][Full Text] [Related]
31. Adherence to follow-up examination after positive fecal occult blood test results affects colorectal cancer mortality: A Korea population-based cohort study.
Kim YJ; Shim JI; Park E; Kang M; Kang S; Lee J; Tchoe HJ; Kong KA; Kim DH; Kim BC; Choi KS; Moon CM
Dig Liver Dis; 2021 May; 53(5):631-638. PubMed ID: 33676856
[TBL] [Abstract][Full Text] [Related]
32. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
33. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic testing following fecal occult blood screening in the elderly.
Lurie JD; Welch HG
J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project.
Paszat L; Rabeneck L; Kiefer L; Mai V; Ritvo P; Sullivan T
Can J Gastroenterol; 2007 Jun; 21(6):379-82. PubMed ID: 17571172
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of complete diagnostic examination in clinical practice settings.
Jimbo M; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS; Myers RE
Cancer Detect Prev; 2006; 30(6):545-51. PubMed ID: 17113240
[TBL] [Abstract][Full Text] [Related]
37. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
38. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience.
Grazzini G; Castiglione G; Isu A; Mantellini P; Rubeca T; Sani C; Turco P; Zappa M
Tumori; 2000; 86(5):384-8. PubMed ID: 11130566
[TBL] [Abstract][Full Text] [Related]
40. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
Lipkus IM; Green LG; Marcus A
J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
